ICG dye during colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial uses a special dye called ICG that is injected during surgery to help the surgeon see the blood flow to your colon and lymph nodes. It may help make the surgery more precise and improve outcomes for colon cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of colon cancer (adenocarcinoma).
- You cannot have emergency surgery for a blocked or perforated bowel.
- You cannot be allergic to ICG dye or have had a severe allergic reaction.
- You cannot be pregnant or breastfeeding.
- You cannot have severe liver failure, because the dye is removed by the liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special dye (indocyanine green) during surgery to remove right-sided colon cancer helps the surgeon see and remove more lymph nodes. The goal is to improve cancer removal without adding extra risks.
This study tests whether using a special dye during surgery helps people with stage III colorectal cancer stay cancer-free longer. The dye, called indocyanine green (ICG), makes tumors and lymph nodes glow under a special camera, helping surgeons remove them more precisely.
This trial tests whether using a fluorescent dye during surgery can help doctors better see and remove lymph nodes in people with right-sided colon cancer. It aims to make surgery more precise and potentially improve outcomes.
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.